Disc Medicine, Inc.
Nasdaq-listed company. Follow earnings, filings, products, capital and the competitive forces moving the company.
What’s moving Disc Medicine, Inc. now
Current reporting with the operating signal separated from the noise.
PR Newswire
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
The story matters when it changes Disc Medicine, Inc.’s customers, execution, competitive position or capital requirements.
Watch next: confirmation in a company filing, official release or regulator record.Latest IRON filings.
Investor-relevant reports are shown first, followed by the company’s other recent official submissions.
10-QQuarterly financial reportFiled 2026-07-30 · Period 2026-06-30SEC ↗10-QQuarterly financial reportFiled 2026-05-05 · Period 2026-03-31SEC ↗10-KAnnual financial reportFiled 2026-02-26 · Period 2025-12-31SEC ↗8-KMaterial company eventFiled 2026-07-30 · Period 2026-07-30SEC ↗8-KMaterial company eventFiled 2026-06-30 · Period 2026-06-25SEC ↗8-KMaterial company eventFiled 2026-06-24 · Period 2026-06-18SEC ↗DEF 14AProxy and shareholder meetingFiled 2026-04-28 · Period 2026-06-18SEC ↗4Official SEC filingFiled 2026-07-14 · Period 2026-07-13SEC ↗
Disc Medicine, Inc., quarter by quarter.
Results, guidance and earnings coverage are grouped only when the source headline identifies the reporting period.
First quarter
No verified period-specific item in the current feed.
SEARCH Q1 COVERAGE →Second quarter
No verified period-specific item in the current feed.
SEARCH Q2 COVERAGE →Third quarter
No verified period-specific item in the current feed.
SEARCH Q3 COVERAGE →Fourth quarter / full year
No verified period-specific item in the current feed.
SEARCH Q4 COVERAGE →